Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma

Clinical trial NCT00722137 · COMPLETED

Trial details

NCT number: NCT00722137
Sponsor: Millennium Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Mantle Cell Lymphoma

Start date: 2008-05-01
Primary completion: 2014-01-01
Enrollment: 487

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.